首页 › 基金 › RiverPark Advisors, LLC › DMAA

RiverPark Advisors, LLC 对 DMAA 的持仓历史

DRUGS MADE IN AMER ACQUTN CO · 金融

RiverPark Advisors, LLC 在 Q3 2026 的 13F 申报中披露持有 DMAA(DRUGS MADE IN AMER ACQUTN CO)264,866 股,市值约 US$2.9M,约占其申报组合的 1.36%,在其申报持仓中市值排名第 24 位。 RiverPark Advisors, LLC 于 Q3 2026 首次申报该持仓。

最新持仓 (Q3 2026)264.87K 股
申报持仓市值$2.88M
组合权重1.36%
首次申报Q3 2026
最近变动新进
更新于2026-11-17

最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR

RiverPark Advisors, LLC 对 DMAA 的持仓演变

RiverPark Advisors, LLC 于 Q3 2026 首次披露 DMAA 持仓:264,866 股(约 US$2.9M)。

逐季持仓明细

季度股数金额变化
Q3 2026 264.87K $2.88M 新进

关于 DMAA 与 13F 数据

DMAA(DRUGS MADE IN AMER ACQUTN CO)属于金融行业。我们追踪的基金中还有 24 只申报持有 DMAA,申报仓位最大的包括:MIZUHO SECURITIES USA LLC (US$40.6M), Karpus Management, Inc. (US$26.9M), First Trust Capital Management L.P. (US$8.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 DMAA 的基金

查看 DMAA 的全部基金持有人 →

常见问题

How long has RiverPark Advisors, LLC held DMAA?

RiverPark Advisors, LLC has disclosed DMAA holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is RiverPark Advisors, LLC's current position in DMAA?

As of Q3 2026, RiverPark Advisors, LLC holds 264.87K shares of DMAA (DRUGS MADE IN AMER ACQUTN CO), valued at $2.88M, representing 1.36% of its reported portfolio and ranking #24.

Has RiverPark Advisors, LLC been buying or selling DMAA?

In the latest 13F filing (Q3 2026), RiverPark Advisors, LLC newly opened its position in DMAA.

Which other funds hold DMAA?

Other major institutional holders of DMAA include MIZUHO SECURITIES USA LLC, Karpus Management, Inc., First Trust Capital Management L.P., among 24 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.